会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 81. 发明申请
    • COMPOSITIONS AND METHODS FOR TREATING MULTIPLE SCLEROSIS
    • 用于治疗多发性硬化症的组合物和方法
    • US20100028441A1
    • 2010-02-04
    • US12430728
    • 2009-04-27
    • Richard L. WatsonAnthony B. WoodGregory J. Archambeau
    • Richard L. WatsonAnthony B. WoodGregory J. Archambeau
    • A61K9/14A61K33/00A61P25/00
    • C12N13/00
    • Provided are electrokinetically-altered fluids (gas-enriched electrokinetic fluids) comprising an ionic aqueous solution of charge-stabilized oxygen-containing nanostructures in an amount sufficient to provide modulation of at least one of cellular membrane potential and cellular membrane conductivity, and therapeutic compositions and methods for use in treating inflammatory neurodegenerative condition or disease or at least one symptom thereof. The electrokinetically-altered fluids or therapeutic compositions and methods include electrokinetically-altered ioinic aqueous fluids optionally in combination with other therapeutic agents. Particular aspects provide for regulating or modulating intracellular signal transduction associated with said inflammatory responses by modulation of at least one of cellular membranes, membrane potential, membrane proteins such as membrane receptors, including but not limited to G-Protein Coupled Receptors (GPCR), and intercellular junctions (e.g., tight junctions, gap junctions, zona adherins and desmasomes). Other embodiments include particular routes of administration or formulations for the electrokinetically-altered fluids (e.g., electrokinetically-altered gas-enriched fluids and solutions) and therapeutic compositions.
    • 提供了电动改变的流体(富含气体的电动液体),其包含足以提供细胞膜电位和细胞膜电导率中的至少一种的调节的电荷稳定的含氧纳米结构的离子水溶液,以及治疗组合物和 用于治疗炎症性神经变性疾病或疾病或其至少一种症状的方法。 电动改变的流体或治疗组合物和方法包括任选与其它治疗剂组合的电动改变的碘代水性流体。 特定方面提供调节或调节与所述炎症反应相关的细胞内信号转导,通过调节细胞膜,膜电位,膜蛋白如膜受体(包括但不限于G-蛋白偶联受体(GPCR))和 细胞间连接(例如,紧密连接,间隙连接,zona adherins和desmasomes)。 其他实施方案包括用于电动改变的流体(例如,电动改变的富含气体的流体和溶液)和治疗组合物的特定给药途径或制剂。
    • 82. 发明申请
    • METHODS OF WOUND CARE AND TREATMENT
    • 治疗方法和治疗方法
    • US20100021464A1
    • 2010-01-28
    • US12431704
    • 2009-04-28
    • Gregory J. ArchambeauRichard L. WatsonAnthony B. Wood
    • Gregory J. ArchambeauRichard L. WatsonAnthony B. Wood
    • A61K33/00A61K39/395A61P17/02
    • A61K9/0048A61K9/0014A61K33/00A61K45/06A61L15/44A61L26/0066A61L2300/404A61L2300/412A61L2300/426B01F3/04531B01F3/0807B01F3/0853B01F7/00816B29D11/00038A61K2300/00
    • Provided are electrokinetically-altered fluids (e.g., gas-enriched electrokinetic fluids) comprising an ionic aqueous solution of charge-stabilized oxygen-containing nanostructures in an amount sufficient to provide modulation of at least one of cellular membrane potential and cellular membrane conductivity, and therapeutic compositions and methods for use in treating a wound to a surface tissue or a symptom thereof. The electrokinetically-altered fluids or therapeutic compositions and methods include electrokinetically-altered ionic aqueous fluids optionally in combination with other therapeutic agents. Particular aspects provide for regulating or modulating intracellular signal transduction associated with said inflammatory responses by modulation of at least one of cellular membranes, membrane potential, membrane proteins such as membrane receptors, including but not limited to G-Protein Coupled Receptors (GPCR), and intercellular junctions (e.g., tight junctions, gap junctions, zona adherins and desmasomes). Other embodiments include particular routes of administration or formulations for the electrokinetically-altered fluids (e.g., electrokinetically-altered gas-enriched fluids and solutions) and therapeutic compositions.
    • 提供了电动改变的流体(例如,富含气体的电动液),其包含电荷稳定的含氧纳米结构的离子水溶液,其量足以提供细胞膜电位和细胞膜电导率中的至少一种的调节,以及治疗 用于治疗伤口至表面组织或其症状的组合物和方法。 电动改变的流体或治疗组合物和方法包括任选与其它治疗剂组合的电动改变的离子水性流体。 特定方面提供调节或调节与所述炎症反应相关的细胞内信号转导,通过调节细胞膜,膜电位,膜蛋白如膜受体(包括但不限于G-蛋白偶联受体(GPCR))和 细胞间连接(例如,紧密连接,间隙连接,zona adherins和desmasomes)。 其他实施方案包括用于电动改变的流体(例如,电动改变的富含气体的流体和溶液)和治疗组合物的特定给药途径或制剂。
    • 83. 发明申请
    • COMPOSITIONS AND METHODS FOR TREATING ASTHMA AND OTHER LUNG DISORDERS
    • 用于治疗哮喘和其他肺功能障碍的组合物和方法
    • US20090274771A1
    • 2009-11-05
    • US12259101
    • 2008-10-27
    • Richard L. WatsonAnthony B. WoodGregory J. Archambeau
    • Richard L. WatsonAnthony B. WoodGregory J. Archambeau
    • A61K33/00A61P11/00
    • A61K33/00A61K31/43A61K31/431A61K45/06A61K2300/00
    • Provided are compositions and methods for treating or preventing lung or respiratory disorders or conditions characterized by airflow obstruction or limitation, or a symptom thereof (e.g., asthma, rhinitis, allergic rhinitis (e.g. nose respiratory tract), and chronic obstructive pulmonary disease (COPD) and COPD-associated conditions (e.g., bronchitis, emphysema, asthma), emphysema, pneumonia, bronchitis, influenza, SARS, tuberculosis, and whooping cough (pertussis), and the like) in a subject in need thereof by administering a therapeutic composition comprising at least one electrokinetically generated fluid (including gas-enriched electrokinetically generated fluids) as disclosed herein, the electrokinetically altered aqueous fluid suitable to alter cellular membrane structure or function sufficient to provide for modulation of intracellular signal transduction, wherein treating a lung disorder or a symptom thereof is thereby afforded. Additional aspects relate to therapeutic compositions, and combination treatment methods comprising administration of at least one electrokinetically generated fluid in combination with at least one additional therapeutic agent.
    • 提供用于治疗或预防肺或呼吸系统疾病或由气流阻塞或限制或其症状(例如,哮喘,鼻炎,过敏性鼻炎(例如鼻呼吸道)和慢性阻塞性肺病(COPD))的症状的组合物和方法, 和COPD相关的病症(例如,支气管炎,肺气肿,肺气肿,肺炎,支气管炎,流行性感冒,SARS,肺结核和百日咳(百日咳)等)在有需要的受试者中通过施用治疗组合物, 至少一种电动产生的流体(包括富含气体的电动产生的流体),如本文所公开的,电动改变的水性流体适于改变足以提供细胞内信号转导调节的细胞膜结构或功能,其中治疗肺病或症状 由此得到。 另外的方面涉及治疗组合物和组合治疗方法,其包括与至少一种另外的治疗剂组合施用至少一种电动产生的流体。
    • 84. 发明申请
    • MIXING DEVICE
    • 混合装置
    • US20080281001A1
    • 2008-11-13
    • US11924595
    • 2007-10-25
    • Anthony B. WoodGregory J. ArchambeauRichard L. Watson
    • Anthony B. WoodGregory J. ArchambeauRichard L. Watson
    • B01F3/04G05D11/13
    • B01F5/0665A23L2/54A61J3/00A61K9/08A61K9/10A61K33/00B01F3/04099B01F3/04531B01F3/0807B01F3/0853B01F7/008B01F7/00816C02F1/727C02F3/02C09K3/00C12M27/00Y02W10/15
    • Particular aspects provide compositions comprising an electrokinetically altered oxygenated aqueous fluid, wherein the oxygen in the fluid is present in an amount of at least 25 ppm. In certain aspects, the electrokinetically altered oxygenated aqueous fluid comprises electrokinetically modified or charged oxygen species present in an amount of at least 0.5 ppm. In certain aspects the electrokinetically altered oxygenated aqueous fluid comprises solvated electrons stabilized by molecular oxygen, and wherein the solvated electrons present in an amount of at least 0.01 ppm. In certain aspects, the fluid facilitates oxidation of pyrogallol to purpurogallin in the presence of horseradish peroxidase enzyme (HRP) in an amount above that afforded by a control pressure pot generated or fine-bubble generated aqueous fluid having an equivalent dissolved oxygen level, and wherein there is no hydrogen peroxide, or less than 0.1 ppm of hydrogen peroxide present in the electrokinetic oxygen-enriched aqueous fluid.
    • 具体方面提供了包含电动改变的含氧水溶液的组合物,其中流体中的氧以至少25ppm的量存在。 在某些方面,电动改变的含氧水性流体包含以至少0.5ppm的量存在的电动改性或带电的氧物质。 在某些方面,电动改变的含氧水性流体包含由分子氧稳定的溶剂化电子,并且其中溶剂化电子以至少0.01ppm的量存在。 在某些方面,流体有助于在辣根过氧化物酶(HRP)存在下将连苯三酚氧化成紫罗卜糖苷,其量高于由产生的对照压力罐或具有等效溶解氧水平的微小气泡产生的水性流体所提供的量,并且其中 在电动性富氧水溶液中不存在过氧化氢或少于0.1ppm的过氧化氢。